Lubberman FJE - Search Results

1

Reasons for non-feasibility of therapeutic drug monitoring of oral targeted therapies in oncology - an analysis of the closed cohorts of a multicentre prospective study.

van der Kleij MBA, Guchelaar NAD, Meertens M, Westerdijk K, Giraud EL, Bleckman RF, Groenland SL, van Eerden RAG, Imholz ALT, Vulink AJE, Otten HM, Fiebrich-Westra HB, Lubberman FJE, Desar IME, Moes DAR, Touw DJ, Koolen SLW, Gelderblom H, Reyners AKL, van Erp NP, Mathijssen RHJ, Huitema ADR; Dutch Pharmacology Oncology Group (DPOG); Steeghs N. van der Kleij MBA, et al. Among authors: lubberman fje. Br J Cancer. 2024 Sep;131(5):843-851. doi: 10.1038/s41416-024-02789-2. Epub 2024 Jul 6. Br J Cancer. 2024. PMID: 38971952 Free PMC article.

2

Folate, folic acid, and chemotherapy-induced toxicities: A systematic literature review.

Zwart NRK, Franken MD, Tissing WJE, Lubberman FJE, McKay JA, Kampman E, Kok DE. Zwart NRK, et al. Among authors: lubberman fje. Crit Rev Oncol Hematol. 2023 Aug;188:104061. doi: 10.1016/j.critrevonc.2023.104061. Epub 2023 Jun 21. Crit Rev Oncol Hematol. 2023. PMID: 37353179 Free article. Review.

3

The impact of a 1-hour time interval between pazopanib and subsequent intake of gastric acid suppressants on pazopanib exposure.

Krens SD, Lubberman FJE, van Egmond M, Jansman FGA, Burger DM, Hamberg P, Vervenne WL, Gelderblom H, van der Graaf WTA, Desar IME, van Herpen CML, van Erp NP. Krens SD, et al. Among authors: lubberman fje. Int J Cancer. 2021 Jun 1;148(11):2799-2806. doi: 10.1002/ijc.33469. Epub 2021 Jan 19. Int J Cancer. 2021. PMID: 33428771 Free PMC article.

4

A prospective phase I multicentre randomized cross-over pharmacokinetic study to determine the effect of food on abiraterone pharmacokinetics.

Lubberman FJE, Benoist GE, Gerritsen W, Burger DM, Mehra N, Hamberg P, van Oort I, van Erp NP. Lubberman FJE, et al. Cancer Chemother Pharmacol. 2019 Dec;84(6):1179-1185. doi: 10.1007/s00280-019-03952-w. Epub 2019 Sep 12. Cancer Chemother Pharmacol. 2019. PMID: 31515667 Free PMC article. Clinical Trial.

5

The effect of gastrectomy on regorafenib exposure and progression-free survival in patients with advanced gastrointestinal stromal tumours.

Lubberman FJE, van der Graaf WTA, Xu L, Cleton A, Demetri GD, Gelderblom H, van Erp NP. Lubberman FJE, et al. Br J Clin Pharmacol. 2019 Oct;85(10):2399-2404. doi: 10.1111/bcp.14061. Epub 2019 Aug 19. Br J Clin Pharmacol. 2019. PMID: 31290566 Free PMC article.

6

The Effect of Using Pazopanib With Food vs. Fasted on Pharmacokinetics, Patient Safety, and Preference (DIET Study).

Lubberman FJE, Gelderblom H, Hamberg P, Vervenne WL, Mulder SF, Jansman FGA, Colbers A, van der Graaf WTA, Burger DM, Luelmo S, Moes DJAR, van Herpen CML, van Erp NP. Lubberman FJE, et al. Clin Pharmacol Ther. 2019 Nov;106(5):1076-1082. doi: 10.1002/cpt.1515. Epub 2019 Jul 9. Clin Pharmacol Ther. 2019. PMID: 31125423 Clinical Trial.

7

Fasting conditions in clinical oncology trials and drug labelling - Authors' reply.

Lubberman FJE, Burger D, van Erp NP. Lubberman FJE, et al. Lancet Oncol. 2017 Sep;18(9):e507. doi: 10.1016/S1470-2045(17)30599-5. Lancet Oncol. 2017. PMID: 28884695 No abstract available.

8

Does a glass of Coke boost the exposure to imatinib in gastrointestinal stromal tumour patients after gastrectomy?

Lubberman FJE, Gelderblom H, Wilmer CM, Kweekel DM, Desar IME, Colbers A, Burger D, van der Graaf WTA, van Erp N. Lubberman FJE, et al. Br J Clin Pharmacol. 2017 Oct;83(10):2312-2314. doi: 10.1111/bcp.13333. Epub 2017 Jul 4. Br J Clin Pharmacol. 2017. PMID: 28677263 Free PMC article. Clinical Trial. No abstract available.

9

Poorly specified fasting conditions in clinical research could lead to treatment failure.

Lubberman FJE, Burger D, van Erp NP. Lubberman FJE, et al. Lancet Oncol. 2017 May;18(5):571-573. doi: 10.1016/S1470-2045(17)30249-8. Lancet Oncol. 2017. PMID: 28495277 No abstract available.

10

Boosting axitinib exposure with a CYP3A4 inhibitor, making axitinib treatment personal.

Lubberman FJE, van Erp NP, Ter Heine R, van Herpen CML. Lubberman FJE, et al. Acta Oncol. 2017 Sep;56(9):1238-1240. doi: 10.1080/0284186X.2017.1311024. Epub 2017 Apr 7. Acta Oncol. 2017. PMID: 28388255 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

12 results

Search Page

Filters